[28H-pm] Pharmacotherapies (Cancer)-2

[28H-pm08S] Incidence and risk factors of infusion reactions in breast cancer patients administered pertuzumab combination chemotherapy

○Yusuke Tabuchi^1,2, Masayuki Tsujimoto², Kosuke Yamamoto³, Tadashi Kosaka¹, Koichi Sakaguchi⁴, Naoya Dobuchi³, Kohshi Nishiguchi², Keisuke Shikata¹ (1. Dept. of Pharm., Univ. Hosp., Kyoto Pref. Univ. of Med., 2. Dept. of Clinical Pharmacy, Kyoto Pharmaceutical Univ., 3. Dept. of Pharm., Univ. Hosp., North Medical Center Kyoto Pref. Univ. of Med., 4. Dept. of Endocrine and Breast Surgery, Grad. School of Medical Science, Kyoto Pref. Univ. of Med.)